thrombolytics + ICP backup Flashcards

1
Q

simple explanation of Tenecteplase role

A

accelerates the breakdown of clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Heparin role simple explanation

A

short acting anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

enoxaparin basic role

A

long acting anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clopidogrel basic role

A

antiplatelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

tenecteplase preparation

A

Glass ampoule containing 50 mg of tenecteplase, in powder form with a pre-filled syringe containing 10 ml of sterile water.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is tenecteplase

A

fibrinolytic that accelerates the breakdown of blood clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tenecteplase MOA

A

Tenecteplase accelerates the breakdown of clots by stimulating TPA (tissue plasminogen activator, an enzyme) to facilitate the increased conversion of plasminogen to plasmin, resulting in a breakdown of fibrin ( the mesh casing of vessels).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ILS indcation of tenectplase

A

STEMI when following the fibrinolytic pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

contradictions of tenectplase

A

allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cautions of tenectaplse

A

Clinically significant bleeding.
More than ten minutes of CPR.
Non-compressible vascular puncture within the last 24 hours.
Internal bleeding within the last six weeks.
Lumbar puncture or epidural insertion within the last six weeks.
TIA within the last three months.
Known bleeding disorder.
Taking an anticoagulant. If the patient is taking warfarin document their last known INR result if possible.
Systolic BP greater than 180 mmHg or diastolic BP greater than 110 mmHg.
Known to be pregnant or less than two weeks postpartum.
Time of onset of symptoms was greater than 12 hours ago.
Dependent on others for activities of daily living.
Another disease significantly shortens their life expectancy.
Very frail.
Suspected aortic dissection.
Major surgery, major trauma or severe brain injury within the last six weeks.
Intracranial surgery within the last six months.
Ischaemic stroke within the last six months.
Previous intracerebral haemorrhage.
Known cerebral aneurysm, arteriovenous malformation or tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

tenectaplase and pregency?

A

seek clinical advise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

administration of tenectplase

A

Follow weight based medication chart
Dissolve the powder using the syringe within the kit.
Carefully discard unwanted drug from the syringe, preferably into the ampoule before administration, ensuring the correct dose remains in the syringe.
If an error is made in discarding unwanted drug and the correct dose cannot be drawn up, administer the remaining drug, document this well, and notify the receiving clinician.

Administer undiluted as an IV bolus, preferably into a running IV line.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

advese effects of tenectaplase

A

Bleeding. Tenecteplase commonly causes superficial bleeding, including epistaxis, bruising and bleeding from IV sites.

Dysrhythmia. It is common for dysrhythmia to occur if the coronary artery reperfuses. Most commonly the rhythm is accelerated idioventricular rhythm (AIVR) which does not require specific treatment. Other dysrhythmias should be treated using the appropriate section.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

onset of tenectplase

A

5-10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

duration of tenectplasse

A

2-6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

interactions of tenectplase

A

nil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

enoxaparin preparation

A

Pre-filled syringe containing 100 mg in 1 ml.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is enoxaparin

A

low molecular weight heparin (LMWH) anticoagulant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

enoxaparin mechanism

A

Enoxaparin increases the activity of antithrombin lll (a naturally occurring anticoagulant, inhibits clotting ) causing inhibition of multiple coagulation factors including clotting factor II (thrombin) and factor 10 Xa (which makes fibrin). thrombin is unable to convert fibrinogen to fibrin and form a clot.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ILS enoxaparin indication

A

STEMI in conjunction with fibrinolytic therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

contraindction of enoxaparin

A

allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

cautions of enoxaparin

A

Clinically significant bleeding. Enoxaparin will increase bleeding.
At risk of bleeding. If there are any cautions present within the fibrinolytic therapy checklist, personnel must seek clinical advice or discuss with the STEMI coordinator prior to administration.
Pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

admin of eneoxaparin

A

Administer subcutaneously into the abdominal wall.
There is no need to sterilise the skin at the site of injection unless the skin is visibly contaminated.
Discard unwanted drug from the syringe before administration.
If an error is made in discarding unwanted drug volume and the dose remaining in the syringe is less than planned, administer the remaining dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

adverse effects of eneoxparin

A

increased bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

onset of enoxoparin

A

10-30 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

duration of enoxaparin

A

12-24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

common interactions of eneoxoparin

A

risk of bleeding increases if the patient is taking an anticoagulant

28
Q

preparation of clopidogrel

A

75 mg tablets

29
Q

what is clopeidegrel

A

an antiplatlet

30
Q

mechanism of clopidogrel

A

platelet inhibitor that irreversibly bind to ADP receptors on platelets, imparting their function thus decreasing aggregation

31
Q

indication for clopedigerl

A

STEMI in conjunction with fibrinolytic therapy.

32
Q

contridicaitons of clopidogrel

33
Q

cautions of clopidogrel

A

Clinically significant bleeding. Clopidogrel will increase bleeding.

At risk of bleeding. If there are any cautions present within the fibrinolytic therapy checklist, personnel must seek clinical advice.

Pregnancy.

34
Q

dosage and admin of clopidogrel

A

administer PO:
300 mg if the patient is aged less than 75 years.

75 mg if the patient is aged greater than or equal to 75 years

35
Q

adverse effects of clopidogrel

A

increased bleeding

36
Q

clopidogrel onset

A

30-60 mins

37
Q

clopidogrel duration

A

3-5 days- full life of that platelet

38
Q

clopidogrel common interactions

A

risk of bleeding if anticoagulanted

39
Q

heparin prepration

A

Ampoule containing 5000 units.

40
Q

what is heparin

A

Heparin is an anticoagulant.

41
Q

heparin mech

A

Inhibits antithrombin III, which prevents the activation of thrombin altering the clotting cascade by preventing the conversion of fibrinogen to fibrin thus slowing and or preventing the formation of clots.

Heparin dose not contribute to lysis or breakdown of clots

42
Q

heparin IND

A

STEMI in conjunction with fibrinolytic therapy.

43
Q

heparin contras

A

KSA

Aged greater than or equal to 75 years. When heparin is administered in combination with fibrinolytic therapy in patients aged greater than or equal to 75 years, there is an increased risk of intracerebral haemorrhage.

44
Q

heparin cautions

A

Clinically significant bleeding. Heparin will increase bleeding.

At risk of bleeding. If there are any cautions present within the fibrinolytic therapy checklist, personnel must seek clinical advice prior to administration.
Pregnancy.

45
Q

admin and dosage of heparin

A

→5000 units.Dilute to a total volume of 10 ml using 0.9% sodium chloride.Administer IV over 1-2 minutes.

46
Q

adverse effects of heparin

A

increased bleeding

47
Q

onset of heparin

A

5-15 minutes

48
Q

duration of heparin

49
Q

common interactions of heparin

A

The risk of bleeding will be increased if the patient is taking an anticoagulant.

50
Q

criteria for RSI

A

✅A GCS less than or equal to 10, and
✅Clinically significant compromise of airway or ventilation.

51
Q

why do we RSI

A

The primary goal of performing RSI is to improve patient outcomes by securing the airway, treating hypoxia and controlling ventilation to prevent hypercarbia. This is particularly important in patients who are unconscious post cardiac arrest or have severe TBI, because secondary brain injury worsens long-term outcomes.

52
Q

timeframe consideration for RSI

A

Personnel calling for backup from an ICP endorsed to perform RSI must take into account how long it will take for backup to arrive. In order to be appropriately utilised, such backup must arrive at least 15 minutes faster than the patient can be transported to an appropriate hospital.

53
Q

role of sodium bicarb

A

normalisation of extracellular and intracellular pH, raising serum pH to combat clinical manifestations of acidosis/hyperkalemia/electrolyte imbalances

54
Q

indications to call ICP for sodium bicarb

A

✅Release syndrome following crush injury in an adult.
✅Known or suspected hyperkalaemia with severe ECG changes.
✅Cardiac arrest secondary to hyperkalaemia.
✅Suspected cyclic antidepressant poisoning with QRS prolongation.

55
Q

IND to call ICP for Ropivacaine

A

Indications:
✅Severe pain associated with clinically obvious fractured neck of femur or fractured proximal shaft of femur, where pain has not been adequately controlled with an opiate and transport time (including extrication time) to hospital is greater than 30 minutes. (Fascia iliaca blocks)
✅Moderate to severe pain associated with isolated injuries to digits when transport time is greater than 60 minutes. (e.g. digit)

56
Q

meteraminol indications

A

✅Hypotension in the setting of septic shock, post cardiac arrest, cardiogenic shock, severe traumatic brain injury, neurogenic shock, rapid sequence intubation and post intubation.

57
Q

adenosine indications

A

✅Patients aged greater than or equal to 12 years with SVT and a ventricular rate greater than or equal to 150/minute, and
The patient is not severely compromised, and
The rhythm fails to revert following two Valsalva manoeuvres.

58
Q

labetalol indications

A

✅Control of hypertension prior to fibrinolytic therapy for STEMI.
✅Control of hypertension during inter-hospital transfer for STEMI.
✅Control of hypertension during inter-hospital transfer for stroke clot retrieval.
✅Control of hypertension associated with autonomic dysreflexia.

59
Q

ICP ketamine indications

A

✅Inducing dissociation.
✅Acute behavioural disturbance causing a severe to ✅immediately life-threatening risk to safety.
✅Rapid sequence intubation (RSI).
✅Significant movement during CPR that is interfering with resuscitation.
✅Asthma with severe agitation that is impairing the ability to safely provide treatment or transport.

60
Q

calcium chloride indications

A

✅Release syndrome following crush injury in adults.
✅Suspected hyperkalaemia with severe ECG changes.
✅Cardiac arrest secondary to suspected hyperkalaemia.

61
Q

what can you consult for hydrocortisone out of scope

A

adrenal crisis
severe asthma unable to take prednisone

62
Q

out of scope ketamine consult indications

A

ABD
dissociation for cardioversion
movement in CPR

63
Q

out of scope magnesium inds

A

severe COPD of asthma
torards de point
ecampsia
pre eclampsia

64
Q

what is the preferred sedation for a patient who has not responded or n/a droperidol, if under the influence of meth

A

midazolam over ketamine

65
Q

what is primary hemostasis

A

It is caused when bleeding ceases or gets reduced by contraction of the blood vessels, and thrombin signals for platelet assembly and forms a loose platelet plug

66
Q

what is secondary hemostasis

A

It includes the action of blood proteins and coagulation factors in a sequence to reinforce the platelet plug and marks the onset of the healing process. Blood coagulation is provoked by the extrinsic pathway i.e. tissue damage, but the intrinsic pathway (internal messengers) intensifies the coagulation.

Coagulation of blood is a lengthy process occurring within a few minutes where numerous coagulation factors come into play.